KARA FITZGERALD, ND completed a post-doctorate in nutritional biochemistry/laboratory science with Richard Lord, Ph.D. Author: Case Studies in Integrative and Functional Medicine, contributing author: Laboratory Evaluations for Integrative and Functional Medicine; IFM’s Textbook for Functional Medicine. She lectures globally on functional medicine; is on faculty at IFM and practices in Connecticut.

Billions paid out over potential ties between talc powder and Roundup, and cancer

Two important legal battles reached decision points on settlements and damages recently – one against Johnson & Johnson’s talc products and the other against Monsanto’s Roundup, both for causing cancers. If you don’t already avoid these products, we recommend that you do. Johnson & Johnson is ordered to pay $2.1 billion to women who claim…

covid-19 new research

COVID Antibodies Decline, But The Question About Lasting Immunity is Still Unanswered

Protective antibodies against COVID-19 may only last a short time after infection, new evidence shows. However, it doesn’t mean that scientists have definitively answered the question about lasting immunity for this particular virus. The current thinking is that even low levels of powerful neutralizing antibodies may still be protective – after all, the immune system…

Podcast Album Cover

Making Functional Medicine Accessible and Profitable with James Maskell

COVID19 is upon us. Months earlier, we scheduled James Maskell to discuss his recent book: The Community Cure. Amazingly, his message today is all the more urgent. James argues for the group visit model, was an early adopter and proponent of group visits (in fact, we discuss the pre-publication Cleveland Clinic group visit research findings, which are astonishingly good; even better than the first JAMA publication comparing functional medicine one-on-one with family medicine.) Now, with COVID19 and self-isolation, the virtual visit and the virtual group visit (where James saw FxMed eventually going) is upon us. And specifically, his vision is that this model works in insurance- and even Medicare. James’ message – the promise of functional medicine – is timely, inspiring and essential. ~DrKF

Podcast album cover

Episode 86: Sponsored | Panoramic Microbial Assessment: The GI360™ Stool Test with David Quig, PhD

The GI360 is a smart, evidenced-based stool test that is easily actionable by the clinician. Listen to my conversation today with VP of Scientific Support from Doctor’s Data, Dr. David Quig. One of the most useful tools I am aware of in stool testing is the Dysbiosis Test, which identifies and characterizes more than 45 targeted analytes across six Phyla using PCR and compares the patient results to a characterized normobiotic reference population. DDI is also using the Luminex PCR panel for pathogens, parasites and viruses – an FDA cleared panel for accurate detection of microbes that are almost always a problem. But what if they are not? Hear my discussion with Dr. Q on that. Finally, beta glucuronidase – it’s SO MUCH more complex than we’ve understood. Yes, we’re aware of the estrogen connection, but the BG story has evolved. We also walk through the chemistries – DDI includes a wide range of chems (appreciated by me and my colleagues here in our practice!). Give a listen, and leave us a review wherever you listen to New Frontiers! Thank you! ~DrKF

No Further Trials Needed to Determine if Omega-3 Fats Reduce the Risk of Cardiovascular Disease and Death

This new meta-analysis indicates that ‘no further trials are needed to better evaluate the efficacy of PUFAs in preventing death related to CVD”. A total of 100,609 patients were analyzed. Reduction in mortality due to cardiovascular issues was statistically significant with a relative risk of 0.937, CI 0.88-0.98, P=0.018. Is it time to put this decades-long debate to bed? We think so.

Higher Serum Chemicals Linked with Celiac Disease

Having increased exposure to environmental chemicals, such as those found in pesticides, non-stick cookware, and fire retardants, is positively associated with increased incidence of Celiac Disease. Specifically, young individuals with high serum levels of dichlorodiphenyldichloroethylene (DDE) are twice as likely to have developed Celiac Disease. When looking at females only, the risk is even greater…